CTNNB1 activating mutations enhance β-catenin protein stability and facilitate its translocation to and accumulation in the nucleus, where β-catenin binds to the TCF/LEF transcription factors and subsequently drives transactivation of many target genes, thereby promoting tumor initiation and progression [9]. Here, HNF4A is linked to neoplasm.